Francine Healy

Francine Healy has over 22 years of scientific research experience, including 13 years of neuroscience research in pharmaceutical drug development at Bristol-Myers Squibb and in academia at Yale School of Medicine. Prior to joining Biohaven, Francine spent the previous 8 years in the Global Scientific and Regulatory Documentation group at Bristol-Myers Squibb where she was responsible for development and implementation of regulatory document strategy. Her experience spans across multiple therapeutic areas including neuroscience, oncology, immunology, and immuno-oncology. Her work has supported numerous successful global filings, approvals, and other regulatory commitments across the US, EU, and Japan.